June 20, 2017
UC Davis Health welcomes 145 migrant high school students Sunday, June 25 for a day of tours, talks and opportunities to learn more about medical science from students, fellows and faculty.
June 6, 2017
With its internationally renowned school of veterinary medicine and its NCI-designated comprehensive cancer center, UC Davis is uniquely positioned to harness the power of each to tackle one of life’s greatest challenges: cancer.
June 2, 2017
David R. Gandara, professor and director of thoracic oncology at UC Davis Comprehensive Cancer Center, has been named a “Giant of Cancer Care” in lung cancer by OncLive in recognition of his work to advance the field of oncology through his contributions in research and clinical practice.
May 24, 2017
UC Davis has signed a licensing agreement providing Isotropic Imaging Corporation the rights to commercialize a novel computed tomography (CT) scanner that has the potential to improve breast cancer detection and positively impact women’s health.
May 10, 2017
Former UC Davis Medical Center Chief Executive Officer Robert E. Chason passed away on May 8, 2017, following a brief illness. He was 73.
April 25, 2017
Sean Collins, assistant professor of microbiology and molecular genetics in the UC Davis College of Biological Sciences, has received a Kimmel Scholar Award from the Sidney Kimmel Foundation.
April 25, 2017
Patients in California hospitals were more likely to die within 60 days of being diagnosed with acute myeloid leukemia – a cancer of the blood and bone marrow – if they were unmarried, lived in a less-affluent neighborhood or lacked health insurance. The UC Davis study also found that patients treated at a National Cancer Institute (NCI)-designated cancer center were more likely to survive.
April 20, 2017
Second cancers in children and adolescents and young adults (AYA) are far deadlier than they are in older adults and may partially account for the relatively poor outcomes of cancer patients ages 15-39 overall, a new study by UC Davis researchers has found.
March 23, 2017
In a new study published today in JCI Insight, UC Davis researchers have shown that combining high-intensity focused ultrasound with two immunotherapies (a PD-1 checkpoint inhibitor and TLR9 agonist) can produce excellent response rates in mouse models of epithelial cancer. They also found that, for the combination to be effective, immunotherapies must come first.
March 21, 2017
Three UC Davis programs are featured in a new documentary produced by KVIE that explores non-pharmacological approaches to helping people heal.
February 23, 2017
Researchers at UC Davis have received $3.2 million in federal funds to further investigate how obesity and inflammation affect the body’s immune system in fighting cancer.
February 7, 2017
UC Davis physician researchers have found that medical marijuana contains multiple bacterial and fungal pathogens that may cause serious and even fatal infections. They warn that smoking, vaping or inhaling aerosolized marijuana could pose a grave risk to patients, especially those with leukemia, lymphoma, AIDS or conditions requiring immune-suppressing therapies.
January 26, 2017
January 19, 2017
A large team of researchers from UC Davis and several European and Latin American institutions have identified genetic variations that contribute to familial gastric cancer. These inherited mutations, which affect the PALB2, BRCA1 and RAD51C genes and have been implicated in other cancer types, impair a critical DNA repair mechanism called homologous recombination. These findings could improve preventive care, as well as provide targets for new therapies. The study was published last month in the journal Gastroenterology.
January 18, 2017
A national study by researchers at UC Davis Comprehensive Cancer Center has found that a significant number of lung cancer patients are not receiving treatment. Based on data between 1998 and 2012 from the National Cancer Database, 21 percent of patients (190,539) with non-small cell lung cancer (NSCLC) received no specific cancer treatment, such as chemotherapy, radiotherapy or surgery. Many of the untreated patients were women, elderly, minorities, low income and uninsured.
January 17, 2017
The UC Davis-based EXPLORER consortium, which aims to build a revolutionary total-body PET (positron emission tomography) scanner, has announced the selection of two industry partners to help build the prototype device. They are United Imaging Healthcare America, a North American subsidiary of Shanghai United Imaging Healthcare, and SensL Technologies of Cork, Ireland.
January 11, 2017
Recognizing a critical need to improve national vaccination rates for the human papillomavirus (HPV), UC Davis Comprehensive Cancer Center has again united with each of the 69 National Cancer Institute (NCI)-designated cancer centers in issuing a joint statement in support of recently revised recommendations from the U.S. Centers for Disease Control and Prevention (CDC).
January 9, 2017
UC Davis Health has entered into an agreement with Top Grade Health Care to establish a translational research and development center to advance the treatment of patients with cancer.
December 12, 2016
A large trial by UC Davis professor David Gandara has found that the immunotherapy atezolizumab was superior to chemotherapy for patients with advanced non-small-cell lung cancer.
November 16, 2016
Jacquelyn Conway, a mother who enjoys taking long walks and cooking organic meals, was told she had invasive breast cancer In August 2012. That began an arduous series of cancer treatments starting with chemotherapy – and a determined approach to survival.
November 15, 2016
Alan Ashworth, renowned basic cancer scientist and president of the UCSF Helen Diller Comprehensive Cancer Center, will present a talk on synthetic lethal approaches to cancer therapy Nov. 30 at UC Davis.
November 3, 2016
UC Davis Comprehensive Cancer Center now offers a new technique for breast cancer patients undergoing surgery to remove breast cancer that may improve cosmetic outcomes and the patient’s surgery experience.
October 25, 2016
Patients with disseminated advanced cancer who undergo surgery are far more likely to endure long hospital stays and readmissions, referrals to extended care facilities and death, UC Davis researchers have found.
October 20, 2016
Painful sex in women after cancer treatment is relatively common, often treatable and needs to be addressed by medical providers, a UC Davis oncologist and researcher suggests.
October 18, 2016
Young adults dealing with the effects of cancer are invited to attend Pushing Past Cancer, a free day of education and motivation, on Saturday, Nov. 5, from 9:30 a.m. to 5 p.m. at the UC Davis Sacramento campus. The event is open to cancer patients ages 18-40, their support persons and medical professionals.
October 13, 2016
The National Institutes of Health (NIH) has named the California Precision Medicine Consortium as a regional medical center group in the national network of health care provider organizations that will implement the Precision Medicine Initiative (PMI) Cohort Program.
October 4, 2016
More than 80 people attended the 4th annual Cancer Care Network Symposium Saturday at the UC Davis Comprehensive Cancer Center auditorium to explore key topics in cancer care, including the new End of Life Option Act.
September 23, 2016
Kit Lam, professor and chair of the UC Davis Department of Biochemistry and Molecular Medicine, has received two major cancer research grants totaling more than $3 million.
September 20, 2016
Kit Lam, professor and chair of the UC Davis Department of Biochemistry and Molecular Medicine, has been appointed to the National Cancer Institute’s Basic Science Board of Scientific Counselors (BSC).
September 9, 2016
Training oncologists and their patients to have high-quality discussions improves communication, but troubling gaps still exist between the two groups, according to a new study in JAMA Oncology.
September 8, 2016
Marking Ovarian Cancer Awareness Month and the need for more research and education about the disease, Let’s ROC, the annual 5K run is set for Sunday, Sept. 18 at 8 a.m.
September 7, 2016
The cancer center's pharmacist-driven oral anti-cancer medication adherence program, led by Iris C. Zhao, has earned the 2016 California Society of Health System Pharmacist’s (CSHP) Innovative Pharmacy Practice Award.
September 6, 2016
The National Cancer Institute has again funded the K12 Paul Calabresi Clinical Oncology Training Grant to promote and sustain the development of young cancer scientists from diverse fields and from laboratories and clinics across both UC Davis campuses.
August 31, 2016
A new report from the UC Davis Institute for Population Health Improvement (IPHI) shows the impact of cancer screening over the past 15 years, identifying areas where increased screening and other cancer-control efforts would save lives and significantly benefit population health.
August 26, 2016
Hmong Americans are more likely to understand the importance of colorectal cancer screening and to get screened when they’re provided information by specially trained Hmong lay health educators, new research from UC Davis has found.
August 22, 2016
Becker’s Hospital Review has named UC Davis Health System one of 100 in the country with “great oncology programs.”
August 5, 2016
The Prostate Cancer Foundation and Movember, the global charity that has raised hundreds of millions for men’s health research and programs, have delivered $1 million to UC Davis prostate cancer researchers.